Brendan Teehan
Chief Commercial Officer · Pacira BioSciences, Inc.
- 2024
- Feb 13, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brendan Teehan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- Shawn Cross - $895K in PCRX purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
- Kristen Williams - $498K in PCRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brendan Teehan?
Brendan Teehan is a corporate insider, tracked as Chief Commercial Officer of Pacira BioSciences, Inc. (PCRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Brendan Teehan last file a Form 4?
The most recent primary Form 4 on record is dated 13 February 2026, one of 3 filings going back to 2024.
Has Brendan Teehan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($174K) across all tracked filings.
